Skip to content

Drug interactions

Sirolimus + Tucatinib

Severity: Major

Sirolimus and Tucatinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tucatinib inhibits CYP3A and can substantially raise exposure to sensitive CYP3A substrates such as sirolimus. Higher sirolimus levels increase the risk of toxicity including myelosuppression, hyperlipidemia, impaired wound healing, and infection.

What this interaction means in plain words

Sirolimus and Tucatinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Sirolimus belongs to Miscellaneous; Tucatinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Tucatinib inhibits CYP3A4-mediated metabolism of sirolimus, increasing its systemic exposure.

What to do

Avoid the combination if possible; if necessary, reduce the sirolimus dose and monitor trough concentrations closely. Re-adjust the dose after tucatinib is stopped.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Sirolimus and Tucatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Sirolimus with Tucatinib?

MediHelp rates the interaction as major. Sirolimus and Tucatinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Tucatinib inhibits CYP3A and can substantially raise exposure to sensitive CYP3A substrates such as sirolimus. Higher sirolimus levels increase the risk of toxicity including myelosuppression, hyperlipidemia, impaired wound healing, and infection.

How serious is the interaction between Sirolimus and Tucatinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible; if necessary, reduce the sirolimus dose and monitor trough concentrations closely. Re-adjust the dose after tucatinib is stopped.

What other medicines interact with Sirolimus?

MediHelp also lists interactions of Sirolimus with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Sirolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in